Princess Margaret Hospital
Toronto, Ontario, M5G 2M9, Canada
NCT Number: NCT00152789
This study is based on previous observation that, in men with localized prostate cancer, non-cancerous prostate tissue is hypoxic, and on the known contribution of hypoxia to the progression of cancer. Patients undergoing diagnostic prostate biopsy with serum prostate specific antigen (PSA) less than 10ng/ml and who have given informed consent will have oxygen measurements of the prostate and peri-prostatic tissue taken with the Eppendorf electrode at the time of biopsy. The oxygenation of normal prostate tissue will be compared to that of cancerous prostate tissue. In men with negative biopsies, the prostate tissue oxygen measurements will be compared with the peri-prostatic tissue oxygen measurements.
Looking for future studies?
Notify Me18 year and older
Male
Interventional
Phase 2
Toronto, Ontario, M5G 2M9, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 years
Time frame: 7 years
University Health Network, Toronto
Other
Oxygenation of the Prostate Gland: a Polarographic Electrode Study in Men Undergoing Prostate Biopsy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04108208
Genital Diseases, Genital Diseases, Male
Beijing, China
View Trial DetailsNCT03834493
Genital Diseases, Genital Diseases, Male
Mobile, Alabama, United States
View Trial DetailsNCT02854982
Genital Diseases, Genital Diseases, Male
Nîmes, Gard, France
View Trial DetailsNCT03421015
Disease Attributes, Genital Diseases
Lille, France
View Trial Details